Loading clinical trials...
Loading clinical trials...
Treatment Protocol for High-Risk PNET Brain Tumors in Children With Surgery, Sequential Chemotherapy, Conventional and High-Dose With Peripheral Blood Stem Cell Transplantation and Radiation Therapy
The purpose of this study is to evaluate the efficacy of the combination of surgery, conventional chemotherapy, sequential high-dose chemotherapy with peripheral blood stem cell transplantation and reduced dose radiation therapy in high-risk PNET brain tumors.
Age
0 - 10 years
Sex
ALL
Healthy Volunteers
No
Institut Gustave Roussy
Villejuif, France
Start Date
July 1, 2002
Last Updated
September 18, 2007
71
ESTIMATED participants
Etoposide, carboplatin, melphalan, cisplatin, thiotepa
DRUG
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
NCT07420543
NCT05535166
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07087002